FDA Inspection 1340796 — Department Of Defense-Navy; US Naval Hospital Yokosuka

Department Of Defense-Navy; US Naval Hospital Yokosuka — FEI 3002809468

The FDA completed an inspection of Department Of Defense-Navy; US Naval Hospital Yokosuka on Sep 18, 2026 in Yokosuka. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Sep 18, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Yokosuka (Japan)